Therapeutic agents useful for treating pain

Details Therapeutic agents useful for treating pain Therapeutic agents useful for treating pain

2011-08-30

2011-08-30

Sackey, Ebenezer O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S254040, C514S254060, C544S238000, C544S357000, C544S368000, C544S370000

Reexamination Certificate

active

08008300

ABSTRACT:
A compound of formula:wherein Ar1, A, R3, x, and m are as disclosed herein and Ar2is a benzothiazolyl, benzooxazolyl, or benzoimidazolyl group or a pharmaceutically acceptable salt thereof (a “Benzoazolylpiperazine Compound”), compositions comprising a Benzoazolylpiperazine Compound, and methods for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia, or depression in an animal comprising administering to an animal in need thereof an effective amount of a Benzoazolylpiperazine Compound are disclosed.

REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 5039680 (1991-08-01), Imperato et al.
patent: 5059595 (1991-10-01), Le Grazie
patent: 5073543 (1991-12-01), Marshall et al.
patent: 5075341 (1991-12-01), Mendelson et al.
patent: 5120548 (1992-06-01), McClelland et al.
patent: 5198459 (1993-03-01), Imperato et al.
patent: 5232934 (1993-08-01), Downs
patent: 5354556 (1994-10-01), Sparks et al.
patent: 5529998 (1996-06-01), Habich et al.
patent: 5536721 (1996-07-01), Jakobsen et al.
patent: 5556837 (1996-09-01), Nestler et al.
patent: 5556838 (1996-09-01), Mayer et al.
patent: 5574052 (1996-11-01), Rose et al.
patent: 5591767 (1997-01-01), Mohr et al.
patent: 5639476 (1997-06-01), Oshlack et al.
patent: 5674533 (1997-10-01), Santus et al.
patent: 5698155 (1997-12-01), Grosswald et al.
patent: 5733566 (1998-03-01), Lewis
patent: 5762925 (1998-06-01), Sagan
patent: 6109269 (2000-08-01), Rise et al.
patent: 6136839 (2000-10-01), Isakson et al.
patent: 6150129 (2000-11-01), Cook et al.
patent: 6204284 (2001-03-01), Beer et al.
patent: 6239267 (2001-05-01), Duckworth et al.
patent: 6335180 (2002-01-01), Julius et al.
patent: 6406908 (2002-06-01), McIntyre et al.
patent: 6482479 (2002-11-01), Dubal et al.
patent: 7754723 (2010-07-01), Sun et al.
patent: 2004/0152690 (2004-08-01), Balan et al.
patent: 11-199573 (1999-07-01), None
patent: 2003-192673 (2003-07-01), None
patent: WO 99/26927 (1999-06-01), None
patent: WO 99/37304 (1999-07-01), None
patent: WO 00/59510 (2000-10-01), None
patent: WO 01/10846 (2001-02-01), None
patent: WO 01/57008 (2001-08-01), None
patent: WO 02/08221 (2002-01-01), None
Bartho et al., “Involvement of Capsaicin-sensitive Neurones in Hyperalgesia and Enhanced Opioid Antinociception in Inflammation,” Naunyn-Schmiedeberg's Archives of Pharmacology 342:666-670 (1990).
Berkow et al., (eds), “Seizure Disorder”, The Merck Manual of Medical Information 345-350 (1997).
Berkow et al., (eds), “Crohn's Disease”, The Merck Manual of Medical Information 528-530 (1997).
Berkow et al., (eds), “Irritable Bowel Syndrome”, The Merck Manual of Medical Information 525-526 (1997).
Berkow et al., (eds), “Peptic Ulcer”, The Merck Manual of Medical Information 496-500 (1997).
Berkow et al., (eds), “Stroke”, The Merck Manual of Medical Information 352-355 (1997).
Berkow et al., (eds), “Ulcerative Colitis”, The Merck Manual of Medical Information 530-532 (1997).
Berkow et al., (eds), “Urinary Incontinence”, The Merck Manual of Medical Information 631-634 (1997).
Brunton, “Agents for control of gastric acidity and treatment of peptic ulcers”, Goodman and Gilman's The Pharmacological Basis of Therapeutics 901-915 (J. Hardman and L. Limbird eds., 9thed. 1996).
Buchwald et al., “Long-term, continuous intravenous heparin administration by an implantable infusion pump in ambulatory patients with recurrent venous thrombosis”, Surgery 88 (4):507-16 (1980).
Chiamulera et al., “Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice”, Nat Neurosci. 4(9):873-4 (2001).
Chu-Moyer et al., “Orally-effective, log-acting sorbitol dehydrogenase inhibitors: synthesis, structure-activity relationships, and in vivo evaluations of novel heterocycle-substituted piperazino-pyrimidines”, J. Med. Chem. 45:511-528 (2002).
Cooke et al., “Glycopyrrolate in bladder dysfunction”, S. Afr. Med. J. 63(1):3 (1983).
D'Amour et al., “A Method for Determining Loss of Pain Sensation,” J. Pharmacol. Exp. Ther. 72:74-79 (1941).
Dogrul et al., “Peripheral and spinal antihyperalgesic activity of SIB-1757, a metabotropic glutamate receptor (mGLUR(5)) antagonist, in experimental neuropathic pain in rats”, Neurosci Lett. 292(2):115-8 (2000).
During et al., “Controlled release of dopamine from a polymeric brain implant: in vivo characterization”, Ann. Neurol. 25(4):351-6 (1989).
Foley, Pain, in Cecil Textbook of Medicine 100-107 (J.C. Bennett and F. Plum eds., 20th ed. 1996).
Goodson, “Dental applications”, in Medical Applications of Controlled Release, supra, vol. 2, pp. 115-138 (1984).
Grupp et al., “Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts”, J. Mol. Cell. Cardiol. 31(1):297-303 (1999).
Hanson, Analgesic, Antipyretic and Anti-Inflammatory Drugs in Remington: The Science and Practice of Pharmacy vol. II 1196-1221 (A.R. Gennaro ed. 19th ed. 1995).
Hargreaves et al., “A New and Sensitive Method for Measuring Thermal Nociception in Cutaneous Hyperalgesia, ”Pain 32(1):77-88 (1998).
Herzog et al., “Urinary incontinence: medical and psychosocial aspects”, Annu. Rev. Gerontol. Geriatr. 9:74-119 (1989).
Howard et al., “Intracerebal drug delivery in rats with lesion-induced memory deficits”, J. Neurosurg. 71(1):105-12 (1989).
Insel, Analgesic-Antipyretic and Anti-inflammatory Agents and Drugs Employed in the Treatment of Gout, in Goodman & Gilman's The Pharmacological Basis of Therapeutics 617-57 (Perry B. Molinhoff and Raymond W. Ruddon eds., 9thed 1996).
Khadse et al., “Synthesis and Study of 2-(N4-substituted-N1-piperazinyl) pyrido (3,2-d) thiazoles, 5-nitro-2-(N4-substituted-N1-piperazinyl) Benzthiazoles and allied compounds as possible anthelmintic agents”, Bull. Haff. Instt. 1(3):27-32 (1975).
Kim, “An Experimental Model for Peripheral Neuropathy Produced by Segmental Spinal Nerve Ligation in the Rat,” Pain 50(3):355-363 (1992).
Langer, “New methods of drug delivery”, Science. 249(4976):1527-33 (1990).
Levin et al., “Direct measurement of the anticholinergic activity of a series of pharmacological compounds on the canine and rabbit urinary bladder,” J. Urol. 128(2)396-8 (1982).
Levy et al., “Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate”, Science, 228(4696):L190-2 (1985).
Masu et al., “Sequence and expression of a metabotropic glutamate receptor”, Nature 349(6312):760-5 (1991).
Miller et al., “Growth Factor Upregulation of a Phosphoinositide-Coupled Metabotropic Glutamate Receptor Cortical Astrocytes”, J. Neurosci. 15(9):6103-6109 (1995).
Mirakhur et al., “Glycopyrrolate: pharmacology and clinical use”, Anaesthesia 38(12):1195-204 (1983).
Wein et al., “Pharmacology of incontinence”, Urol. Clin. North Am. 22(3):557-77 (1995).
Orjales et al., “New 2-Pieperazinylbenzimidazole Derivatives as 5-HT3Antagonists. Synthesis and Pharmacological Evaluation”, J. Med. Chem. 40:586-593 (1997).
Ossowska et al., “Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats”, Neuropharmacology 41(4):413-20 (2001).
Langer et al., “Chemical and physical structure of polymers as

Affiliated with

Also associated with

Rating

Therapeutic agents useful for treating pain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agents useful for treating pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agents useful for treating pain will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2675388